Open AccessEstimation of Prognosis in Invasive Cutaneous Melanoma: An Independent Study of the Accuracy of a Gene Expression Profile Test
Author(s) -
Bradley N. Greenhaw,
John A. Zitelli,
David G. Brodland
Publication year - 2018
Publication title -
dermatologic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.659
H-Index - 125
eISSN - 1524-4725
pISSN - 1076-0512
DOI - 10.1097/dss.0000000000001588
Subject(s) - medicine , oncology , melanoma , test (biology) , cohort , predictive value , metastasis , disease , metastatic melanoma , pathology , cancer , cancer research , paleontology , biology
Cutaneous melanomas (CMs) with similar clinical and histopathologic features can harbor differing capacities for metastasis. A validated gene expression profile (GEP) test offers prognostic information by classifying CMs as low risk (Class 1A/1B) or high risk (Class 2A/2B) for metastasis.